The White House budget office on Monday (Aug. 6) started reviewing a plan by the HHS Inspector General to seek advice from stakeholders on anti-kickback law reforms, a little more than two weeks after it began reviewing a proposed rule from the IG on anti-kickback safe harbors for drug rebates. The request for information on anti-kickback law might apply to policies beyond those related to drugs, but lobbyists aren’t ruling out drug-price implications. HHS officials have said that a request...